DITEX
Price
$12.55
Change
-$0.04 (-0.32%)
Updated
Jan 10 closing price
Net Assets
379.23M
NMBAX
Price
$8.73
Change
-$0.03 (-0.34%)
Updated
Jan 10 closing price
Net Assets
7.66B
Ad is loading...

DITEX vs NMBAX

Header iconDITEX vs NMBAX Comparison
Open Charts DITEX vs NMBAXBanner chart's image
BNY Mellon Intermediate Municipal Bond
Price$12.55
Change-$0.04 (-0.32%)
VolumeN/A
Net Assets379.23M
Nuveen Intermediate Duration Muni Bd A
Price$8.73
Change-$0.03 (-0.34%)
VolumeN/A
Net Assets7.66B
DITEX vs NMBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DITEX vs. NMBAX commentary
Jan 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DITEX is a Hold and NMBAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
NMBAX has more cash in the bank: 7.66B vs. DITEX (379M). NMBAX pays higher dividends than DITEX: NMBAX (2.68) vs DITEX (2.39). DITEX was incepted earlier than NMBAX: DITEX (41 years) vs NMBAX (30 years). NMBAX is a more actively managed with annual turnover of: 21.00 vs. DITEX (14.58). DITEX has a lower initial minimum investment than NMBAX: DITEX (2500) vs NMBAX (3000). NMBAX annual gain was more profitable for investors over the last year : 1.37 vs. DITEX (0.73). NMBAX return over 5 years is better than : 3.42 vs. DITEX (1.57).
DITEXNMBAXDITEX / NMBAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years30 years-
Gain YTD-0.397-0.45687%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets379M7.66B5%
Annual Yield % from dividends2.392.6889%
Returns for 1 year0.731.3753%
Returns for 3 years-1.30-1.3199%
Returns for 5 years1.573.4246%
Returns for 10 years12.0711.32107%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTS0.45N/A
+0.81%
Abits Group
JWN24.01-0.08
-0.33%
Nordstrom
ARES175.04-7.26
-3.98%
Ares Management Corp
CRDF3.61-0.30
-7.55%
Cardiff Oncology
NTLA10.20-1.82
-15.14%
Intellia Therapeutics